GGrantIndex
Sort

53,477 grants matching addiction

Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence

$551,353
David Fiellin · Yale University · R01 · FY2011 · DA

Project 2: Understanding Adolescent Trajectories, Exposures and Suscep

$551,343
Mary Ellen Wewers · Ohio State University · P50 · FY2017 · CA

Chronic Stress of Maltreatment: Drug Use Vulnerability

$551,311
University Of Rochester · R01 · FY2004 · DA

Dissemination of a MI-Based Preparatory Procedure

$551,301
Kimberly S. Walitzer · State University Of New York At Buffalo · R01 · FY2007 · AA

Organizational Change and Nicotine Dependence Treatment

$551,281
Joseph R Guydish · University Of California, San Francisco · R01 · FY2010 · DA

Treatment of Nicotine Dependence Among African-Americans

$551,237
University Of Texas Md Anderson Can Ctr · R01 · FY2002 · CA

Novel treatments of fracture repair and bone pain

$551,117
Fletcher A White · Indiana University Indianapolis · R01 · FY2025 · AR

Translational Research on Eating Disorders: Reward Systems

$551,102
B. Timothy Walsh · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2011 · MH

Molecular mechanisms underlying methamphetamine action and neurotoxicity

$551,003
Hui Shen · National Institute On Drug Abuse · ZIA · FY2021 · DA

ADOLESCENT ALCOHOL TREATMENT OUTCOME--RECOVERY PATTERNS

$550,939
Sandra A Brown · University Of California, San Diego · R37 · FY2007 · AA

Microfabricated all-diamond microelectrode arrays for neurotransmitter sensing and extracellular recording

$550,925
Wen Li · Michigan State University · R01 · FY2024 · NS

Development and Use of rtfMRI for Self-control of Nicotine Craving

$550,907
Jon-Kar Zubieta · University Of Michigan At Ann Arbor · R33 · FY2011 · DA

Administrative Core

$550,903
Rick A Bevins · University Of Nebraska Lincoln · P20 · FY2020 · GM

Naltrexone for the treatment of Actively-Using Met-Dependent MSM with High-Risk B

$550,847
Phillip O Coffin · Public Health Foundation Enterprises · R01 · FY2014 · DA

AN EVALUATION OF THE OXFORD HOUSE MODEL

$550,819
De Paul University · R01 · FY2001 · AA

Molecular and Dynamic Insights into the Function of GPCRs Involved in Drug Abuse

$550,817
Marta Filizola · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · DA

Synaptic Actions of Amphetamine in the Striatum

$550,811
Stephen G Rayport · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2025 · DA

Prenatal & Environment Tobacco Smoke (ETS) Exposure: Effects on Child Regulation

$550,802
Rina D Eiden · State University Of New York At Buffalo · R01 · FY2007 · DA

HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids

$550,788
Pedro Mateu-Gelabert · National Development And Research Institutes, Inc. · R01 · FY2017 · DA

Ca2+-Dependent Block by Mematine and Selective Inhibition of Overactive NMDA Receptors

$550,771
Jon W. Johnson · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AG

Influence of Orexin Antagonism on Motivation for Cocaine

$550,763
William Walton Stoops · University Of Kentucky · R01 · FY2019 · DA

Prevalence of DSM-IV Disorders in an Multi-Center HIV+ Women's Cohort

$550,733
Judith A Cook · University Of Illinois At Chicago · R01 · FY2011 · MH

Dissemination of a MI-Based Preparatory Procedure

$550,699
State University Of New York At Buffalo · R01 · FY2004 · AA

Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence

$550,640
Cynthia I Campbell · Kaiser Foundation Research Institute · R01 · FY2017 · DA

Biomarkers for predicting response to Hsp90 therapy

$550,587
Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA